A revision of the EU Public Procurement Directive (PPD) presents a critical opportunity to ensure a sustainable, competitive, and resilient medicines supply.The European Commission (EC) should consider the following evidence-based reforms: 1.
VIA
Viatris
Company · United States · EU Transparency Register 940251520152-08
2
positions filed
in the 326 files tracked
2
legislative files
of 326 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 925 companies & groups on this site, they rank #519 by legislative files engaged — a count of participation, not a measure of influence.
1.2
declared lobbying FTE
self-declared
€300K+
declared costs / yr (floor)
2
EP accreditations
as declared to the register
2016
in the register since
Declares membership of
- Medicines for Europe (MfE) https://www.medicinesforeurope.com/
- Amcham EU https://www.amchameu.eu/
- Pharma Deutschland Brussels Office: https://www.pharmadeutschland.de/
- US Chamber of Commerce: https://www.uschamber.com/
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Companies & groups
- Registered as
- BGP Products Operations GmbH – a Viatris Company (Viatris)
- Head office
- Steinhausen, Switzerland
- EU office
- Brussels
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Viatris in PolicySpeak: request access →
Work at Viatris? so we know who speaks for it.
Their record over time
Viatris filed 2 positions between 7 Mar 2025 and 26 Jan 2026, across 2 of the 326 legislative files tracked here, attaching a full position paper 1 time.
2025 · 1 filed2026 · 1 filed
What they argued
A revision of the EU Public Procurement Directive (PPD) presents a critical opportunity to foster a sustainable, competitive, and resilient medicines supply. While the PPD (2014/24/EU) encourages a strategic approach through Most Economically Advantageous Tender (MEAT) criteria and limits reliance on price-only tenders, its adoption in medicines procurement remains limited.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- Cefic · 2 files in common
- EDF - Electricité de France · 2 files in common
- DIGITALEUROPE · 2 files in common
- Danish Chamber of Commerce · 2 files in common
- FEAD - European Waste Management Association · 2 files in common
Showing 5 of 128.
Is this your organization?
Everything on this page comes from Viatris’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.